Page last updated: 2024-11-11

hemiasterlin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hemiasterlin A: potent cytotoxic peptide from marine sponge, Hemiasterella minor; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5352091
CHEMBL ID457755
SCHEMBL ID6671779
MeSH IDM0270501

Synonyms (6)

Synonym
NSC695241 ,
hemiasterlin a
CHEMBL457755
hemiasterlins a
(e,4s)-4-[[(2s)-2-[[(2s)-3-(1h-indol-3-yl)-3-methyl-2-(methylamino)butanoyl]amino]-3,3-dimethylbutanoyl]-methylamino]-2,5-dimethylhex-2-enoic acid
SCHEMBL6671779
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID354405Antimitotic activity against human MCF7 cells expressing p53 mutant by MTT assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.
AID354406Cytotoxicity activity against human MCF7 cells expressing p53 mutant by MTT assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]